Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This traditional Chinese medicine (TCM) herbal granule regimen is a combination of eight botanical and animal-derived ingredients: Astragalus (Huangqi), Angelica (Danggui), Red Peony (Chishao), Earthworm (Dilong), Chuanxiong, Safflower (Honghua), Peach Kernel (Taoren), and Butterflybush Flower (Mimenghua). Developed by the Eye Hospital of Wenzhou Medical University, the formulation is designed to be used perioperatively in patients undergoing penetrating canaloplasty (PCP) for primary or juvenile open-angle glaucoma. The regimen aims to mitigate transient postoperative intraocular pressure (IOP) elevation, a common complication of glaucoma surgery. Its mechanism is thought to involve the synergistic effects of its components in promoting blood circulation, resolving stasis, and providing neuroprotection to the optic nerve, thereby improving surgical outcomes and preserving visual function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astragalus + angelica + red peony + earthworm + chuanxiong + safflower + peach kernel + butterflybush flower.